Point72 Hong Kong LTD Catalyst Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $12,416 - $18,223	1,054 New	1,054 $17,000
Q2 2022 Aug 15, 2022	SELL	$6.23 - $8.57 $48,089 - $66,151	-7,719 Reduced 79.82%	1,951 $14,000
Q1 2022 May 16, 2022	BUY	$5.31 - $8.31 $19,848 - $31,062	3,738 Added 63.01%	9,670 $80,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $14,134 - $20,211	2,713 Added 84.28%	5,932 $40,000
Q3 2021 Nov 15, 2021	BUY	$4.85 - $6.04 $15,612 - $19,442	3,219 New	3,219 $17,000
Q4 2020 Feb 16, 2021	SELL	$2.97 - $3.83 $1,678 - $2,163	-565 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.97 - $5.08 $1,678 - $2,870	565 New	565 $2,000
Q1 2020 May 15, 2020	SELL	$2.61 - $5.21 $9,179 - $18,323	-3,517 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.67 - $5.7 $12,907 - $20,046	3,517 New	3,517 $13,000

326

94.6M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.